Table 1.
Effect of epigenetic inhibitors on chemotherapeutic-induced toxicity in prostate cancer cellsa
| + 5-Azab | + CBZ | + TSA | ||||||
|---|---|---|---|---|---|---|---|---|
| LNCaP | PC-3 | LNCaP | PC-3 | LNCaP | PC-3 | LNCaP | PC-3 | |
| Docetaxel | ✓c | ✓ | + | - | - | - | + | - |
| Cisplatin | ✓ | ✓ | - | - | - | - | + | - |
| CFZ | - | ✓ | - | + | - | - | - | - |
Cells were exposed to docetaxel, cisplatin or carfilzomib (CFZ) for 48 hr, after which toxicity was assessed using MTT staining.
Cells were pretreated for 30 min with 5-Aza = 5-azacytidine, CBZ = carbamezapine or TSA = trichostatin A prior to chemotherapeutic exposure.
✓ indicates that the given chemotherapeutic was toxic, while - indicates no significant effect and + indicates increased toxicity in the presence of the specified epigenetic inhibitor.